News

BAC’s CaptureSelect affinity purification and separation products are provided for the discovery, preclinical and clinical manufacturing of therapeutic proteins, including antibodies and antibody fragments. The collaboration creates a

Quotient Clinical’s RapidFACT service exploits its integrated GMP manufacturing and clinical testing processes and facilities to enable the clinical evaluation of new drug formulations. The company claims, compared

Besides being widely used in the production of pharmaceuticals, glycine is a component of infusion solutions and specialty nutrition items. The Germany-based company is investing in a new

Captisol technology was originally developed by Ligand’s subsidiary company CyDex Pharmaceuticals. The technology has enabled five FDA approved products, including Pfizer’s VFEND IV and Prism Pharmaceuticals’ NEXTERONE. Reportedly,

OXECTA, an immediate-release oxycodone HCl medicine, is indicated for the management of acute and chronic moderate to severe pain where the use of an opioid analgesic is appropriate.

The third milestone under the collaboration is expected to enable both the firms to rapidly pursue a development candidate. As a part of the partnership, Jubilant delivers preclinical

The iSPERSE platform enables the delivery of small molecule drugs, drug combinations (including triple drug combinations or higher) and macromolecule drugs at doses well in excess of those

ALD518 is an investigational monoclonal antibody to the pro-inflammatory cytokine IL-6 that is being developed by Bristol-Myers Squibb for autoimmune indications. The Phase 2b randomized, double-blind, placebo controlled

The trial was intended to evaluate the safety, tolerability and pharmacokinetics of 10% solution of luliconazole after maximal use topical application in adults with moderate-to-severe distal subungual onychomycosis